MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
MRTX
Delisted
MRTX was delisted on the 22nd of January, 2024.
177 hedge funds and large institutions have $3.36B invested in Mirati Therapeutics, Inc. Common Stock in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 68 increasing their positions, 57 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
25% less capital invested
Capital invested by funds: $4.48B → $3.36B (-$1.12B)
54% less funds holding in top 10
Funds holding in top 10: 13 → 6 (-7)
Holders
177
Holding in Top 10
6
Calls
$221M
Puts
$159M
Top Buyers
| 1 | +$41.7M | |
| 2 | +$39M | |
| 3 | +$33.6M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$32.3M |
| 5 |
RI
RTW Investments
New York
|
+$26.3M |
Top Sellers
| 1 | -$94M | |
| 2 | -$57.6M | |
| 3 | -$54.1M | |
| 4 |
EC
EcoR1 Capital
San Francisco,
California
|
-$43.1M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$24M |